Dr. Mini Han Wang is a distinguished senior researcher specializing in ophthalmology, artificial intelligence (AI) in medical imaging, and biomolecular pathways in ocular diseases. She holds dual Ph.D.s in Ophthalmology & Visual Sciences from The Chinese University of Hong Kong and Data Science from the City University of Macau, demonstrating her expertise in integrating medical research with AI-driven analytical techniques. Dr. Wang has made significant contributions to age-related macular degeneration (AMD) research, AI-based disease diagnostics, and precision medicine. She currently serves as a Senior Researcher at Zhuhai People’s Hospital, affiliated with the Beijing Institute of Technology and Jinan University, and Director of the Frontier Science Computing Center at the Chinese Academy of Sciences. Beyond research, she is an experienced lecturer, delivering courses on intelligent data mining, evidence-based medicine, and AI applications in healthcare. Her work is widely published in peer-reviewed journals, and she actively collaborates with leading academic and medical institutions. With a commitment to advancing medical AI technologies and personalized healthcare solutions, Dr. Wang stands out as a leading expert at the intersection of medicine and data science.
Professional Profile
Education
Dr. Mini Han Wang has pursued a multidisciplinary academic journey, combining medical sciences, engineering, and data science. She earned a Ph.D. in Ophthalmology & Visual Sciences from The Chinese University of Hong Kong (2022-2025), where her research focuses on AI-driven diagnostics and molecular mechanisms of retinal diseases. In parallel, she completed a Ph.D. in Data Science at the Institute of Data Science, City University of Macau (2020-2023), further enhancing her ability to develop AI-integrated solutions for medical applications. Before her doctoral studies, Dr. Wang completed an M.Sc. in Management (2016-2018) at City University of Macau, gaining insights into research administration and healthcare management. She also holds dual bachelor’s degrees from Jiangxi Science & Technology Normal University (2012-2016) in Internet of Things (IoT) Engineering and English Literature, showcasing her strong foundation in technology and global scientific communication. As an Outstanding Graduate Representative, her diverse educational background enables her to bridge the gap between medical research, AI innovation, and healthcare management, making her a pioneering figure in modern ophthalmic research.
Professional Experience
Dr. Wang’s professional journey is marked by leadership in research, teaching, and AI-driven medical advancements. She currently serves as a Senior Researcher at Zhuhai People’s Hospital, affiliated with Beijing Institute of Technology and Jinan University, where she leads projects on AI-based ophthalmic disease diagnosis and retinal molecular research. Additionally, she holds the position of Director of the Frontier Science Computing Center at the Chinese Academy of Sciences, overseeing cutting-edge AI applications in medicine and multi-omics data integration. Since 2018, Dr. Wang has collaborated with Shenzhen Institute of Advanced Technology and Zhuhai Institute of Advanced Technology, conducting research on medical imaging, knowledge graphs, and AI-driven predictive modeling. Her academic contributions include guest lectures at Beijing Institute of Technology, Jinan University, and Zhuhai Science & Technology Institute, focusing on intelligent data mining, evidence-based medicine, and AI in disease diagnosis. With her interdisciplinary expertise, Dr. Wang has played a key role in bridging fundamental research with clinical applications, contributing significantly to medical AI advancements and personalized treatment strategies.
Research Interest
Dr. Wang’s research revolves around three core areas: ophthalmology, AI in medical imaging, and biomolecular pathways in ocular diseases. Her primary focus is age-related macular degeneration (AMD) and retinal diseases, where she investigates molecular mechanisms, genetic variations, and metabolic dysregulation. She is also deeply involved in AI-driven predictive modeling to enhance early disease detection and precision therapeutics. In the field of medical imaging, she integrates multi-modal imaging techniques (OCT, UWF Fundus) with AI algorithms to improve retinal disease diagnostics and prognosis. Furthermore, her research extends to biomolecular analysis, where she studies oxidative stress, mitochondrial dysfunction, and complement system activation in ocular diseases. By combining multi-omics data, AI-driven drug discovery, and knowledge graph-driven ophthalmic AI systems, Dr. Wang aims to revolutionize personalized medicine and enhance treatment strategies for degenerative eye diseases.
Research Skills
Dr. Wang possesses a diverse and advanced skill set, allowing her to lead high-impact research in medical AI and ophthalmology. She specializes in AI-based predictive modeling, machine learning for medical imaging, and deep learning for disease classification. Her expertise in biomolecular analysis includes multi-omics data integration, pathway analysis, and molecular crosstalk identification for precision medicine applications. Dr. Wang is also proficient in data mining, statistical modeling, and computational biology, which are essential for her research on retinal diseases and AI-driven diagnostics. Additionally, she has hands-on experience with multi-modal imaging techniques (OCT, UWF, fundus photography) and their integration with AI-based disease detection frameworks. She is well-versed in academic writing, research methodology, and project management, with an extensive record of peer-reviewed publications and collaborative research projects. With these skills, Dr. Wang is able to bridge the gap between clinical research and AI-powered healthcare solutions, making her a leading figure in medical innovation.
Awards and Honors
Dr. Wang has received multiple recognitions for her outstanding research contributions and academic achievements. As an Outstanding Graduate Representative, she was acknowledged for her exceptional performance in data science and medical research. She has been the recipient of research grants and funding awards for her work in ophthalmic AI, biomolecular studies, and precision medicine. Her research on AMD and AI-driven diagnostics has earned recognition from international conferences and peer-reviewed journals. She has been invited as a keynote speaker and panelist at various scientific conferences, where she has shared insights on AI applications in medicine, multi-omics integration, and retinal disease research. Additionally, her collaborations with leading universities and medical institutions have led to numerous institutional awards for excellence in research and innovation. With a strong academic and professional track record, Dr. Wang continues to be recognized as a pioneering researcher at the forefront of AI-driven medical advancements.
Conclusion
Dr. Mini Han Wang is a leading researcher at the intersection of ophthalmology, AI, and biomolecular analysis, making groundbreaking contributions to AMD research, AI-driven diagnostics, and precision medicine. Her multidisciplinary expertise in medical science, data analytics, and computational biology allows her to develop innovative solutions for early disease detection and personalized treatment strategies. As a senior researcher, director, and academic lecturer, she has demonstrated leadership in both research and education, mentoring young scientists and collaborating with top-tier institutions. Her work in AI-integrated ophthalmology and molecular disease modeling is shaping the future of medical research and healthcare technology. While further global collaborations, large-scale clinical applications, and expanded research beyond AMD
Publications Top Notes
-
Title: Place attachment to pseudo establishments: An application of the stimulus-organism-response paradigm to themed hotels
Authors: J. Sun, P.J. Chen, L. Ren, E.H.W. Shih, C. Ma, H. Wang, N.H. Ha
Year: 2021
Citations: 86
-
Title: The effect of online investor sentiment on stock movements: an LSTM approach
Authors: G. Wang, G. Yu, X. Shen
Year: 2020
Citations: 43
-
Title: Big data and predictive analytics for business intelligence: A bibliographic study (2000–2021)
Authors: Y. Chen, C. Li, H. Wang
Year: 2022
Citations: 33
-
Title: AI-based advanced approaches and dry eye disease detection based on multi-source evidence: Cases, applications, issues, and future directions
Authors: M.H. Wang, L. Xing, Y. Pan, F. Gu, J. Fang, X. Yu, C.P. Pang, K.K.L. Chong
Year: 2024
Citations: 32
-
Title: Artificial intelligence in ophthalmopathy and ultra-wide field image: A survey
Authors: J. Yang, S. Fong, H. Wang, Q. Hu, C. Lin, S. Huang, J. Shi, K. Lan, R. Tang
Year: 2021
Citations: 29
-
Title: Research on data security in big data cloud computing environment
Authors: F. Wang, H. Wang, L. Xue
Year: 2021
Citations: 27
-
Title: An explainable artificial intelligence-based robustness optimization approach for age-related macular degeneration detection based on medical IoT systems
Authors: M.H. Wang, K.K. Chong, Z. Lin, X. Yu, Y. Pan
Year: 2023
Citations: 26
-
Title: Applications of explainable artificial intelligent algorithms to age-related macular degeneration diagnosis: A case study based on CNN, attention, and CAM mechanism
Authors: M. Wang, Z. Lin, J. Zhou, L. Xing, P. Zeng
Year: 2023
Citations: 13
-
Title: Metamaterials design method based on deep learning database
Authors: X. Zhou, Q. Xiao, H. Wang
Year: 2022
Citations: 10
-
Title: A YOLO-based method for improper behavior predictions
Authors: M. Wang, Y. Zhao, Q. Wu, G. Chen
Year: 2023
Citations: 9